Polaryx Therapeutics (PLYX) Stock Price, Quote, News & History

Polaryx Therapeutics Inc (PLYX) Stock Price, Quote, News & History

PLYXNASDAQ

Trade with Public

$3.52

0.7828.47%

At close: Mar 9, 5:00 PM EST

$3.37

-0.15-4.26%

After Hours: 7:50 PM EST

Key Statistics

Open

$2.72

$3.52

Volume / Avg.

769.98K / 2.60M

Day Range

$2.64 - $3.79

52 Wk Range

2.20 - 48.91

Market Cap

$159.55M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

0.14%

Days to Cover

Recent Polaryx Therapeutics, Inc News

What's Going On With Polaryx Therapeutics Stock Wednesday?

Polaryx Therapeutics Inc. (NASDAQ: PLYX) stock fell after a surge due to a major clinical development announcement.

Kaustubh Bagalkote

Dow Gains 100 Points; Analog Devices Posts Upbeat Q1 Earnings

Avi Kapoor

Small Cap Polaryx Picks Research Partner, Stock Surges on Phase 2 Trial Plans

Polaryx Therapeutics (NASDAQ: PLYX) shares rise on selecting research organization for SOTERIA trial to evaluate lead candidate for lysosomal storage disorders.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-3.31M

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

6.33M

Free Cash Flow (TTM)

-3.31M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

3.01M

Analyst Trends and Forecast

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$129.37M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

24.38

Earnings Yield % (TTM)

-6.35%

Earnings Yield % (FWD)

-4.40%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.11

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$5.75M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$2.72

$3.52

Volume / Avg.

769.98K / 2.60M

Day Range

$2.64 - $3.79

52 Wk Range

2.20 - 48.91

Market Cap

$159.55M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

0.14%

Days to Cover

About

Sector

Health Care

Industry

Pharmaceuticals

Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underly...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Polaryx Therapeutics (PLYX) stock?

You can purchase shares of Polaryx Therapeutics (NASDAQ:PLYX) through any online brokerage.

View our list of the best stock brokerages

Who are Polaryx Therapeutics (PLYX) competitors?

Other companies in Polaryx Therapeutics’s space includes: MediWound Ltd (NASDAQ:MDWD), Aardvark Therapeutics Inc (NASDAQ:AARD), Rani Therapeutics Holdings Inc (NASDAQ:RANI), High Tide Inc (NASDAQ:HITI) and Sol-Gel Technologies Ltd (NASDAQ:SLGL).

What is the forecast, or price target, for Polaryx Therapeutics (PLYX) stock?

Polaryx Therapeutics has a consensus price target of $10.00.

What is the current price for Polaryx Therapeutics (PLYX)?

The stock price for Polaryx Therapeutics (NASDAQ: PLYX) is $3.37 last updated March 9, 2026 at 7:50 PM EDT.

Does Polaryx Therapeutics (PLYX) pay a dividend?

There are no upcoming dividends for Polaryx Therapeutics.

When is Polaryx Therapeutics (NASDAQ:PLYX) reporting earnings?

Polaryx Therapeutics does not have any upcoming earnings scheduled.

Is Polaryx Therapeutics (PLYX) going to split?

There is no upcoming split for Polaryx Therapeutics.

What sector and industry does Polaryx Therapeutics (PLYX) operate in?

Polaryx Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch

MediWound Ltd

NASDAQ:MDWD

$17.49

Aardvark Therapeutics Inc

NASDAQ:AARD

$5.98

-1.81%

Rani Therapeutics Holdings Inc

Sol-Gel Technologies Ltd

NASDAQ:SLGL

$90.00

5.89%

Milestone Pharmaceuticals Inc

IMA

Key Statistics

Open

$2.72

$3.52

Volume / Avg.

769.98K / 2.60M

Day Range

$2.64 - $3.79

52 Wk Range

2.20 - 48.91

Market Cap

$159.55M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

0.14%

Days to Cover

Recent Polaryx Therapeutics, Inc News

What's Going On With Polaryx Therapeutics Stock Wednesday?

Polaryx Therapeutics Inc. (NASDAQ: PLYX) stock fell after a surge due to a major clinical development announcement.

Kaustubh Bagalkote

Dow Gains 100 Points; Analog Devices Posts Upbeat Q1 Earnings

Avi Kapoor

Small Cap Polaryx Picks Research Partner, Stock Surges on Phase 2 Trial Plans

Polaryx Therapeutics (NASDAQ: PLYX) shares rise on selecting research organization for SOTERIA trial to evaluate lead candidate for lysosomal storage disorders.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-3.31M

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

6.33M

Free Cash Flow (TTM)

-3.31M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

3.01M

Analyst Trends and Forecast

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$129.37M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

24.38

Earnings Yield % (TTM)

-6.35%

Earnings Yield % (FWD)

-4.40%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.11

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$5.75M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$2.72

$3.52

Volume / Avg.

769.98K / 2.60M

Day Range

$2.64 - $3.79

52 Wk Range

2.20 - 48.91

Market Cap

$159.55M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

0.14%

Days to Cover

About

Sector

Health Care

Industry

Pharmaceuticals

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry